Northern Survey on Therapeutic Oxygen Prescription

Hannover Medical School500 enrolled

Overview

This is a prospective multicenter observational trial. Included patients and attending physician complete a standardized questionnaire.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Oxygen Toxicity

Interventions

17 items questionaireOTHER

This is a prospective multicenter observational trial. Included patients and attending physician complete a standardised questionnaire.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with chronic lung disease, age \> 18 years * Established domiciliary LTOT \> 4 weeks * Scheduled for control of oxygen therapy with arterial/capillary Exclusion Criteria: * No informed consent * Pulmonary exacerbation within the last 2 weeks * Signs of heart failure (edema, congestion)

Locations (2)

Dep. Respiratory Medicine, Hannover Medical School

Hanover, Germany

RECRUITING

Department of Respiratory Medicine, Medizinische Hochschule Hannover

Hanover, Germany

RECRUITING

Outcomes

Primary Outcomes

Validation of indication of Long-term Oxygen therapy (LTOT)

Aim of this study is to observe the real-world handling with longterm Oxygen treatment in northern Germany

Time frame: 12 month

Central Contacts

Thomas Fühner, PD Dr. med.

CONTACT

+49 531595 fühner.thomas@mh-hannover.de

Heiko Golpon, PD Dr. med.

CONTACT

+49 511 532 golpon.heiko@mh-hannover.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.